31 July 1987
26 September 1986
COMMERCIAL ITEM DESCRIPTION
DEXBROPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE
SULFATE TABLETS (SUSTAINED-RELEASE)
The General Services Administration has authorized the use of this Commercial Item Description.
Shall be Dexbrompheniramine Maleate and Pseudoephedrine Sulfate Tablets, Sustained-Release,
Shall be coated, time-release tablets containing 6 mg of Dexbrompheniramine Maleate and 120 mf of Pseudoephedrine Sulfate.
Shall assay to contain the required amount of Dexbrompheniramine Maleate and Pseudoephedrine Sulfate within the applicable assay limits for the tablets when assayed by suitable, accurate and reproducible method (s).
Materials used in manufacture shall be of pharmaceutical grade.
Workmanship. The Tablets shall be free from defects which detract from their appearance or impair their serviceability.
Unit. Bottle (BT).
For Size 1, one bottle containing 100 tablets, as specified, constitutes one unit.
For Size 2, one bottle containing 1000 tablets, as specified, constitutes one unit.
Contractor certification. The contractor shall certify that the product offered meets the salient characteristics of this description and conforms to the producersí own drawings, specifications, standards, and quality assurance practices. The Government reserves the right to require proof of such conformance prior to first delivery and thereafter as may be otherwise provided for under the provisions of the contract.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business